Trending Now
Moderna Inc (NASDAQ:MRNA) Clinches A Deal For $1.525 Billion To Supply...
Moderna Inc (NASDAQ:MRNA) received an order from the US Government to supply 100 million doses of its mRNA-1273 vaccine. The US Government can also...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Wall Street Reporter Publishes Comments From Pharmadrug Inc (OTCMKTS: LMLLF), Biodesix...
Wall Street recently published comments from the company CEOs of Pharmadrug Inc (OTCMKTS: LMLLF), Biodesix Inc (NASDAQ: BDSX), Nova Mentis Life Sciences (OTCMKTS: NMLSF),...
MAKE IT MODERN
LATEST REVIEWS
The Bitcoin Breakout Could Power These Stocks (PYPL, KULR, MARA, SOS,...
With the launch of the ProShares Bitcoin Strategy ETF (NYSEAMERICAN:BITO), the first real Bitcoin ETF, the next wave of the Bitcoin bull...
MAKE IT MODERN
PERFORMANCE TRAINING
Momentum Stocks Catch Fire as Market Boils (AMC, FCEL, CMGR, MMEDF)
In case you haven’t noticed, the stock market is making your neighbor rich. Feel bad yet? He just bought another sports car...
Intra-Cellular Therapies Inc (NASDAQ: ITCI) Receives Approval From the FDA For Two New CAPLYTA...
The U.S FDA has approved 21mg and 10.5mg CAPYLTA capsules that Intra-Cellular Therapies Inc (NASDAQ: ITCI) made. The two new doses are for patients...
Adcet Bio Inc. (NASDAQ: ACET) Release Preliminary Results From The Phase 1 ADI-001 Dose...
Adcet Bio Inc. (NASDAQ: ACET) has announced encouraging preliminary results from its phase 1 dose-escalation study evaluating tolerability and safety of ADI-001, the company's...
Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Releases Its Q3 2020 Financial Results And Updates On Clinical Development...
Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) has announced an overview and update of its clinical development activities/pipeline and released Q3 2020 financial results.
Ampio provides an update on...
Lineage Cell Therapeutics Inc (NYSEAMERICAN:LCTX) Reveals Positive Findings From The VAC2 Phase 1 Study
Lineage Cell Therapeutics Inc (NYSEAMERICAN:LCTX) recently announced favorable preliminary results from its phase 1 clinical study evaluating VAC2 as a potentially viable treatment for...
MAKE IT MODERN
